Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Nelson Stone

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Prostate

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
79
Stock, Richard
21
Cesaretti, Jamie A.
14
Lehrer, Steven
12
Unger, Pamela
8
Diamond, Edward
7
Droller, Michael
6
Lo, Yeh-Chi
6
Dewyngaert, JK
5
Kao, Johnny
5
Iannuzzi, Christopher
4
Rosenstein, Barry
3
Stock, Richard
3
Kollmeier, Marisa
3
Ferrari, Anna
2
Gallagher, Robert

Sign-in to see all Coauthors

Publications

TOP 3
Stone Nelson N
Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients: oppose.
Stock Richard G; Klein Thomas J; Cesaretti Jamie A; Stone Nelson N
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.
Solan Amy N; Cesaretti Jamie A; Stone Nelson N; Stock Richard G
There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nelson Stone (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Stone Nelson N
Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients: oppose.
Urology 2009;74(4):731-4.
2009: Stock Richard G; Klein Thomas J; Cesaretti Jamie A; Stone Nelson N
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.
International journal of radiation oncology, biology, physics 2009;74(3):753-8.
2009: Solan Amy N; Cesaretti Jamie A; Stone Nelson N; Stock Richard G
There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
International journal of radiation oncology, biology, physics 2009;73(5):1468-74.
2009: Stone Nelson N; Potters Louis; Davis Brian J; Ciezki Jay P; Zelefsky Michael J; Roach Mack; Shinohara Katsuto; Fearn Paul A; Kattan Michael W; Stock Richard G
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2009;73(2):341-6.
2008: Stock Richard G; Cesaretti Jamie A; Unger Pamela; Stone Nelson N
Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.
Brachytherapy 2008;7(3):217-22.
2008: Peters Christopher A; Stock Richard G; Cesaretti Jamie A; Atencio David P; Peters Sheila; Burri Ryan J; Stone Nelson N; Ostrer Harry; Rosenstein Barry S
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.
International journal of radiation oncology, biology, physics 2008;70(3):752-9.
2008: Kao Johnny; Stone Nelson N; Lavaf Amir; Dumane Vishruta; Cesaretti Jamie A; Stock Richard G
(125)I monotherapy using D90 implant doses of 180 Gy or greater.
International journal of radiation oncology, biology, physics 2008;70(1):96-101.
2007: Cesaretti Jamie A; Stone Nelson N; Skouteris Vassilios M; Park Janelle L; Stock Richard G
Brachytherapy for the treatment of prostate cancer.
Cancer journal (Sudbury, Mass.) 2007;13(5):302-12.
2007: Cesaretti Jamie A; Kao Johnny; Stone Nelson N; Stock Richard G
Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up.
BJU international 2007;100(2):362-7.
2007: Cesaretti Jamie A; Stock Richard G; Atencio David P; Peters Sheila A; Peters Christopher A; Burri Ryan J; Stone Nelson N; Rosenstein Barry S
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
International journal of radiation oncology, biology, physics 2007;68(5):1410-6.
2007: Stone Nelson N; Stock Richard G; White Ida; Unger Pam
Patterns of local failure following prostate brachytherapy.
The Journal of urology 2007;177(5):1759-63; duscussion 1763-4.
2007: Stone Nelson N; Stock Richard G
The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume.
The Journal of urology 2007;177(3):925-8.
2007: Stone Nelson N; Stock Richard G
Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years.
Urology 2007;69(2):338-42.
2007: Ho Alice Y; Burri Ryan J; Jennings Glenn T; Stone Nelson N; Cesaretti Jamie A; Stock Richard G
Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer.
Brachytherapy 2007;6(1):38-43.
2007: Zagar Timothy M; Stock Richard G; Cesaretti Jamie A; Stone Nelson N
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.
Brachytherapy 2007;6(1):26-33.
2006: Lehrer Steven; Cesaretti Jamie; Stone Nelson N; Stock Richard G
Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
BJU international 2006;98(5):979-81.
2006: Stock Richard G; Ho Alice; Cesaretti Jamie A; Stone Nelson N
Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control.
International journal of radiation oncology, biology, physics 2006;66(2):389-94.
2006: Peters Christopher A; Cesaretti Jamie A; Stone Nelson N; Stock Richard G
Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.
International journal of radiation oncology, biology, physics 2006;66(2):424-9.
2006: Ferrari Anna C; Stone Nelson N; Kurek Ralf; Mulligan Elizabeth; McGregor Roy; Stock Richard; Unger Pamela; Tunn Ulf; Kaisary Amir; Droller Michael; Hall Simon; Renneberg Heiner; Livak Kenneth J; Gallagher Robert E; Mandeli John
Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3081-8.
2006: Stock Richard G; Cesaretti Jamie A; Stone Nelson N
Disease-specific survival following the brachytherapy management of prostate cancer.
International journal of radiation oncology, biology, physics 2006;64(3):810-6.
2006: Stock Richard G; Stone Nelson N; Cesaretti Jamie A; Rosenstein Barry S
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.
International journal of radiation oncology, biology, physics 2006;64(2):527-33.
2005: Lehrer Steven; Diamond Edward J; Stone Nelson N; Stock Richard G
Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer.
BJU international 2005;96(3):328-9.
2005: Stone Nelson N; Stock Richard G
Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy.
Urology 2005;66(1):119-23.
2005: Lehrer Steven; Diamond Edward J; Mamkine Boris; Droller Michael J; Stone Nelson N; Stock Richard G
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.
BJU international 2005;95(7):961-2.
2005: Kollmeier M A; Stock R G; Cesaretti J; Stone N N
Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
The Journal of urology 2005;173(3):808-12.
2005: Stone Nelson N; Stock Richard G; Unger Pam
Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer.
The Journal of urology 2005;173(3):803-7.
2005: Cesaretti Jamie A; Stock Richard G; Lehrer Steven; Atencio David A; Bernstein Jonine L; Stone Nelson N; Wallenstein Sylvan; Green Sheryl; Loeb Karen; Kollmeier Marisa; Smith Michael; Rosenstein Barry S
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
International journal of radiation oncology, biology, physics 2005;61(1):196-202.
2005: Lehrer Steven; Stone Nelson N; Stock Richard G
Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy.
The Journal of urology 2005;173(1):79-81.
2004: Cesaretti Jamie A; Stone Nelson N; Stock Richard G
Does prior transurethral resection of prostate compromise brachytherapy quality: a dosimetric analysis.
International journal of radiation oncology, biology, physics 2004;60(2):648-53.
2004: Stock Richard G; Cahlon Oren; Cesaretti Jamie A; Kollmeier Marisa A; Stone Nelson N
Combined modality treatment in the management of high-risk prostate cancer.
International journal of radiation oncology, biology, physics 2004;59(5):1352-9.
2004: Stone N N
Brachytherapy or radical prostatectomy: is there a preferred method for treating localized prostate cancer?
BJU international 2004;93(1):5.
2003: Lehrer S; Roboz J; Ding H; Zhao S; Diamond E J; Holland J F; Stone N N; Droller M J; Stock R G
Putative protein markers in the sera of men with prostatic neoplasms.
BJU international 2003;92(3):223-5.
2003: Cesaretti Jamie A; Stone Nelson N; Stock Richard G
Urinary symptom flare following I-125 prostate brachytherapy.
International journal of radiation oncology, biology, physics 2003;56(4):1085-92.
2003: Stock Richard G; Stone Nelson N; Cesaretti Jamie A
Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.
International journal of radiation oncology, biology, physics 2003;56(2):448-53.
2003: Stone Nelson N; Stock Richard G
Practical considerations in permanent brachytherapy for localized adenocarcinoma of the prostate.
The Urologic clinics of North America 2003;30(2):351-62.
2003: Lehrer Steven; Diamond Edward J; Stone Nelson N; Droller Michael J; Stock Richard G; Stone Michelle; Bajwa Asghar; Kornreich Ruth
Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) gene.
Urologic oncology 2003;21(2):101-4.
2003: Stone Nelson N; Stock Richard G
Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
Brachytherapy 2003;2(1):32-9.
2003: Stone Nelson N; Hong Suzanne; Lo Yeh-Chi; Howard Victor; Stock Richard G
Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Brachytherapy 2003;2(1):17-25.
2002: Lehrer Steven; Diamond Edward J; Droller Michael J; Stone Nelson N; Stock Richard G
Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.
Journal of the National Cancer Institute 2002;94(24):1893; author reply 1893-4.
2002: Lehrer Steven; Diamond Edward J; Stone Nelson N; Droller Michael J; Stock Richard G
Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia.
The Journal of urology 2002;168(6):2431-3.
2002: Lehrer S; Diamond E J; Stagger S; Stone N N; Stock R G
Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
British journal of cancer 2002;87(7):726-8.
2002: Stone Nelson N; Stock Richard G
Permanent seed implantation for localized adenocarcinoma of the prostate.
Current urology reports 2002;3(3):201-6.
2002: Stock Richard G; Stone Nelson N
Importance of post-implant dosimetry in permanent prostate brachytherapy.
European urology 2002;41(4):434-9.
2002: Stone N N; Stock R G
Complications following permanent prostate brachytherapy.
European urology 2002;41(4):427-33.
2002: Lehrer Steven; Stone Nelson N; Droller Michael J; Stock Richard G
Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer.
Urologic oncology 2002;7(2):73-6.
2002: Lee Lucille N; Stock Richard G; Stone Nelson N
Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation.
International journal of radiation oncology, biology, physics 2002;52(2):444-52.
2002: Lehrer Steven; Diamond Edward J; Stagger Sharodka; Stone Nelson N; Stock Richard G
Increased serum insulin associated with increased risk of prostate cancer recurrence.
The Prostate 2002;50(1):1-3.
2002: Stone Nelson N; Roy Jiten; Hong Suzanne; Lo Yeh-Chi; Stock Richard G
Prostate gland motion and deformation caused by needle placement during brachytherapy.
Brachytherapy 2002;1(3):154-60.
2002: Stock Richard G; Stone Nelson N
Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer.
Brachytherapy 2002;1(1):2-10.
2002: Stock Richard G; Stone Nelson N; Dahlal Mehud; Lo Yeh Chi
What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms.
Brachytherapy 2002;1(2):83-9.
2001: Snyder K M; Stock R G; Hong S M; Lo Y C; Stone N N
Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis.
International journal of radiation oncology, biology, physics 2001;50(2):335-41.
2001: Stock R G; Kao J; Stone N N
Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer.
The Journal of urology 2001;165(2):436-9.
2000: Lehrer S; McCurdy L D; Stock R G; Kornreich R; Stone N N; Eng C
Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients.
Cancer genetics and cytogenetics 2000;122(2):131-3.
2000: Stock R G; Stone N N; Kao J; Iannuzzi C; Unger P
The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy: implications for treatment optimization.
Cancer 2000;89(8):1829-34.
2000: Stock R G; Stone N N; Lo Y C; Malhado N; Kao J; DeWyngaert J K
Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome.
International journal of radiation oncology, biology, physics 2000;48(3):899-906.
2000: Fang D X; Stock R G; Stone N N; Krynyckyi B R; Kim C K; Machac J
Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy.
Techniques in urology 2000;6(2):146-50.
2000: Stone N N; Ratnow E R; Stock R G
Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation.
Techniques in urology 2000;6(2):123-7.
2000: Stone N N; Stock R G
Dynamic cystography can replace cystoscopy following prostate seed implantation.
Techniques in urology 2000;6(2):112-6.
2000: Stock R G; Stone N N; Lo Y C
Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant.
Techniques in urology 2000;6(2):95-8.
2000: Stone N N; Stock R G; Unger P; Kao J
Biopsy results after real-time ultrasound-guided transperineal implants for stage T1-T2 prostate cancer.
Journal of endourology / Endourological Society 2000;14(4):375-80.
2000: Stone N N; Stock R G
Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetic analysis of implant quality.
International journal of radiation oncology, biology, physics 2000;46(5):1199-204.
2000: Stone N N; Stock R G; Unger P
Effects of neoadjuvant hormonal therapy on prostate biopsy results after (125)I and (103)Pd seed implantation.
Molecular urology 2000;4(3):163-8;discussion 169-70.
1999: Stock R G; Lo Y C; Gaildon M; Stone N N
Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined PD-103 prostate implantation and external beam irradiation.
International journal of radiation oncology, biology, physics 1999;45(2):385-9.
1999: Stone N N; Stock R G
Prostate brachytherapy: treatment strategies.
The Journal of urology 1999;162(2):421-6.
1999: Stock R G; Stone N N
Permanent radioactive seed implantation in the treatment of prostate cancer.
Hematology/oncology clinics of North America 1999;13(3):489-501.
1999: Stone N N; Stock R G
Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
The Mount Sinai journal of medicine, New York 1999;66(1):26-30.
1999: Iannuzzi C M; Stock R G; Stone N N
PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer.
Radiation oncology investigations 1999;7(1):30-5.
1998: Stone N N; Stock R G; Parikh D; Yeghiayan P; Unger P
Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
The Journal of urology 1998;160(5):1722-6.
1998: Stock R G; Ferrari A C; Stone N N
Does pelvic irradiation play a role in the management of prostate cancer?
Oncology (Williston Park, N.Y.) 1998;12(10):1467-72; discussion 1472, 1475-6.
1998: Terk M D; Stock R G; Stone N N
Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.
The Journal of urology 1998;160(4):1379-82.
1998: Lehrer S; Fodor F; Stock R G; Stone N N; Eng C; Song H K; McGovern M
Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
British journal of cancer 1998;78(6):771-3.
1998: Stock R G; Stone N N; Tabert A; Iannuzzi C; DeWyngaert J K
A dose-response study for I-125 prostate implants.
International journal of radiation oncology, biology, physics 1998;41(1):101-8.
1998: Desai J; Stock R G; Stone N N; Iannuzzi C; DeWyngaert J K
Acute urinary morbidity following I-125 interstitial implantation of the prostate gland.
Radiation oncology investigations 1998;6(3):135-41.
1997: Stock R G; Stone N N
The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy.
Seminars in surgical oncology 1997;13(6):454-60.
1997: Stone N N; Stock R G; Unger P
Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques.
The Journal of urology 1997;158(5):1891-4.
1997: Ferrari A C; Stone N N; Eyler J N; Gao M; Mandeli J; Unger P; Gallagher R E; Stock R
Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.
Journal of the National Cancer Institute 1997;89(20):1498-504.
1997: Stock R G; Chan K; Terk M; Dewyngaert J K; Stone N N; Dottino P
A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance.
International journal of radiation oncology, biology, physics 1997;37(4):819-25.
1996: Linzer D G; Stock R G; Stone N N; Ratnow R; Ianuzzi C; Unger P
Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer.
Urology 1996;48(5):757-61.
1996: Stock R G; Stone N N; DeWyngaert J K; Lavagnini P; Unger P D
Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Cancer 1996;77(11):2386-92.
1996: Stock R G; Stone N N; Iannuzzi C
Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.
International journal of radiation oncology, biology, physics 1996;35(2):267-72.
1996: Thall E H; Stone N N; Cheng D L; Cohen E L; Fine E M; Leventhal I; Aldoroty R A
Conservative management of penetrating and blunt Type III renal injuries.
British journal of urology 1996;77(4):512-7.
1995: Stock R G; Stone N N; Ianuzzi C; Unger P
Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
International journal of radiation oncology, biology, physics 1995;33(4):815-21.
1995: Stone N N; Stock R G; Unger P
Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate.
The Journal of urology 1995;154(4):1392-6.
1995: Stone N N; Ramin S A; Wesson M F; Stock R; Unger P; Klein G
Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate.
The Journal of urology 1995;153(5):1555-60.
1995: Stock R G; Stone N N; Wesson M F; DeWyngaert J K
A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation.
International journal of radiation oncology, biology, physics 1995;32(1):219-25.
1995: Stone N N; Garden R J; Weber H
Laparoscopic excision of a urachal cyst.
Urology 1995;45(1):161-4.
1995: Stone N N; Stock R G
Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation.
Techniques in urology 1995;1(2):72-80.
1994: Weiss R E; Stone N N
Persistent maternal hydronephrosis after intra-abdominal pregnancy.
The Journal of urology 1994;152(4):1196-8.
1993: Weiss R E; Garden R J; Stone N N
Isograft bladder mucosal transplantation for hypospadias repair in identical twins.
The Journal of urology 1993;150(6):1884-5.
1993: Stone N N; Schlussel R N; Waterhouse R L; Unger P
Laparoscopic retroperitoneal lymph node dissection in stage A nonseminomatous testis cancer.
Urology 1993;42(5):610-4.
1993: Weiss R E; Garden R J; Cohen E L; Stone N N
Covered exstrophy with sequestered colonic remnant.
The Journal of urology 1993;150(1):185-7.
1993: Hochberg E; Stone N N
Bladder rupture associated with pelvic fracture due to blunt trauma.
Urology 1993;41(6):531-3.
1993: Gordon J N; Aldoroty R A; Stone N N
A spermatic cord hematoma secondary to varicocele rupture from blunt abdominal trauma: a case report and review.
The Journal of urology 1993;149(3):602-3.
1993: Stone N N; Atlas I; Kim U S; Kwan D; Leventhal I; Waxman J S
Renal angiomyolipoma associated with neurofibromatosis and primary carcinoid of mesentery.
Urology 1993;41(1):66-71.
1991: Stone N N; Droller M J
Role of immunotherapy in the treatment of bladder and renal cell carcinoma.
Seminars in surgical oncology 1991;7(4):239-43.
1990: Newman L H; Stone N N; Chircus J H; Kramer H C
Recurrent urethral stricture disease managed by clean intermittent self-catheterization.
The Journal of urology 1990;144(5):1142-3.
1989: Stone M M; Stone N N; Meller S; Kim U
Bilateral ureteral obstruction: an unusual complication of pancreatitis.
The American journal of gastroenterology 1989;84(1):49-51.
1988: Meller S; Stone N N; Waxman J S; Goodman A
Bilateral ureteral necrosis and obliteration secondary to pancreatic pseudocyst.
The Journal of urology 1988;140(6):1523-5.

Sign-in to see more